Vical is dedicated to researching and developing biopharmaceutical products that are based on the company’s patented DNA delivery technologies for preventing and treating serious or life-threatening diseases. The company is internally developing specific infectious disease and cancer therapeutics. Vical additionally collaborates with major pharmaceutical and biotechnology companies, thereby gaining access to complementary technologies and resources that aid in expanding Vical’s product pipeline and addressing important unmet medical needs. For more information, visit the company’s Web site at www.vical.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: